Clobetasol Propionate

×

Overview

What is Clobetasol Propionate?

What does Clobetasol Propionate look like?

What are the available doses of Clobetasol Propionate?

Sorry No records found.

What should I talk to my health care provider before I take Clobetasol Propionate?

Sorry No records found

How should I use Clobetasol Propionate?

Note: For proper dispensing of foam, hold the can upside down and depress the actuator.

Clobetasol propionate foam, 0.05% should be applied to the affected area twice daily, once in the morning and once at night. Invert the can and dispense a small amount of clobetasol propionate foam, 0.05% (up to a maximum of a golf-ball-size dollop or one and a half capfuls) into the cap of the can, onto a saucer or other cool surface, or to the lesion, taking care to avoid contact with the eyes. Dispensing directly onto hands is not recommended (unless the hands are the affected area), as the foam will begin to melt immediately upon contact with warm skin. When applying clobetasol propionate foam, 0.05% to a hair-bearing area, move the hair away from the affected area so that the foam can be applied to each affected area. Pick up small amounts with fingertips and gently massage into affected area until the foam disappears. Repeat until entire affected area is treated.

Apply the smallest amount possible that sufficiently covers the affected area(s). No more than one and a half capfuls of foam should be used at each application. Do not apply to face or intertriginous areas.

Clobetasol propionate foam, 0.05% is a super-high-potency topical corticosteroid; therefore, treatment should be limited to 2 consecutive weeks and amounts greater than 50 g/week should not be used. Use in pediatric patients under 12 years of age is not recommended.

Unless directed by a physician, clobetasol propionate foam, 0.05% should not be used with occlusive dressings.

What interacts with Clobetasol Propionate?

Sorry No Records found

What are the warnings of Clobetasol Propionate?

Sorry No Records found

What are the precautions of Clobetasol Propionate?

Sorry No Records found

What are the side effects of Clobetasol Propionate?

Sorry No records found

What should I look out for while using Clobetasol Propionate?

F

What might happen if I take too much Clobetasol Propionate?

Topically applied clobetasol propionate foam, 0.05% can be absorbed in sufficient amounts 10 produce systemic effects. See PRECAUTIONS.

How should I store and handle Clobetasol Propionate?

Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP] .Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.Codeine SulfateNDC 54868-2541-0: Bottles of 10 TabletsNDC 54868-2541-1: Bottles of 30 TabletsNDC 54868-2541-2: Bottles of 60 Tablets StorageStore at Controlled Room Temperature, 15º to 30ºC (59º to 86ºF). Protect from moisture and light. Dispense in well-closed container as defined in the USP/NF.All opioids are liable to diversion and misuse both by the general public and healthcare workers and should be handled accordingly.

×

Clinical Information

Chemical Structure

No Image found

Clinical Pharmacology

Non-Clinical Toxicology

F

Drug Interactions:

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72

×

Tips

×

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).

Disclaimer: